79 related articles for article (PubMed ID: 11107330)
1. The Funding of Research on the Three Rs in the EU.
Balls M
ALTEX; 1999; 16(4):282-284. PubMed ID: 11107330
[TBL] [Abstract][Full Text] [Related]
2. ["Replacement Methods to Animal Testing" as the incentive topic of the German Ministry of Education and Research. Selected results on biological drugs].
Diekmann W; Hansper M
ALTEX; 2001; 18(1):23-8. PubMed ID: 11248846
[TBL] [Abstract][Full Text] [Related]
3. ECVAM and the Promotion of International Co-operation in the Development, Validation and Acceptance of Replacement Alternative Test Methods.
Balls M
ALTEX; 1999; 16(4):280-282. PubMed ID: 11107329
[TBL] [Abstract][Full Text] [Related]
4. Do we need a "Chair of alternative methods", and where?
Wendel A
ALTEX; 2002; 19(2):64-8. PubMed ID: 12098011
[TBL] [Abstract][Full Text] [Related]
5. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
6. Alternatives to animals in the development and control of biological products for human and veterinary use. The role of the European Pharmacopoeia.
Artiges A
Dev Biol Stand; 1999; 101():29-35. PubMed ID: 10566772
[TBL] [Abstract][Full Text] [Related]
7. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
van der Kamp MD
Dev Biol Stand; 1996; 86():73-6. PubMed ID: 8785994
[TBL] [Abstract][Full Text] [Related]
8. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
9. Collaboration between ZEBET, FRAME, and ECVAM: FRAME's contribution to establishing the Three Rs in Europe.
Spielmann H
Altern Lab Anim; 2009 Dec; 37 Suppl 2():23-7. PubMed ID: 20105007
[TBL] [Abstract][Full Text] [Related]
10. Three Rs potential in the development and quality control of immunobiologicals.
Halder M
ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
[TBL] [Abstract][Full Text] [Related]
11. Alternatives to animal experimentation in basic research.
Gruber FP; Hartung T
ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255
[TBL] [Abstract][Full Text] [Related]
12. A chair on alternatives?
Spielmann H
ALTEX; 2002; 19(2):69-73. PubMed ID: 12098012
[TBL] [Abstract][Full Text] [Related]
13. Alternatives to animal experimentation: the regulatory background.
Garthoff B
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):388-92. PubMed ID: 15982684
[TBL] [Abstract][Full Text] [Related]
14. [The ZEBET database on alternative methods to animal experiments in the Internet--a concrete contribution to the protection of animals].
Grune B; Herrmann S; Dörendahl A; Skolik S; Behnck-Knoblau S; Box R; Spielmann H
ALTEX; 2000; 17(3):127-33. PubMed ID: 11105194
[TBL] [Abstract][Full Text] [Related]
15. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
Sauer UG; Kolar R; Rusche B
ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
[TBL] [Abstract][Full Text] [Related]
16. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment).
Spielmann H; Grune B; Liebsch M; Seiler A; Vogel R
Exp Toxicol Pathol; 2008 Jun; 60(2-3):225-33. PubMed ID: 18440212
[TBL] [Abstract][Full Text] [Related]
17. [White Paper of the European Commission--strategy for a new chemicals policy].
Spielmann H
ALTEX; 2002; 19 Suppl 1():20-5. PubMed ID: 12096326
[TBL] [Abstract][Full Text] [Related]
18. Progress in applying the three Rs of Russell & Burch to the testing of biological products.
Balls M; Halder M
Dev Biol (Basel); 2002; 111():3-13. PubMed ID: 12678219
[TBL] [Abstract][Full Text] [Related]
19. [Establishing ophthalmology in the research framework programs of the European Union].
Scholl HP; Wheeler-Schilling TH; Zrenner E; Holz FG
Ophthalmologe; 2006 Feb; 103(2):91-9. PubMed ID: 16437232
[TBL] [Abstract][Full Text] [Related]
20. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
